Schonfeld Strategic Advisors LLC Compass Pathways PLC Transaction History

Schonfeld Strategic Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$10.73 - $20.07 $1.15 Million - $2.15 Million	-107,100 Reduced 41.58%	150,500 $1.62 Million
Q2 2022 Aug 15, 2022	BUY	$6.76 - $14.18 $1.39 Million - $2.91 Million	205,300 Added 392.54%	257,600 $2.79 Million
Q1 2022 May 16, 2022	SELL	$11.13 - $23.04 $132,012 - $273,277	-11,861 Reduced 18.49%	52,300 $675,000
Q4 2021 Feb 14, 2022	SELL	$21.81 - $48.96 $1.06 Million - $2.37 Million	-48,417 Reduced 43.01%	64,161 $1.42 Million
Q3 2021 Nov 16, 2021	SELL	$29.03 - $38.62 $648,907 - $863,272	-22,353 Reduced 16.57%	112,578 $3.36 Million

Q2 2021 Aug 16, 2021	BUY	$32.29 - $39.68 $4.36 Million - $5.35 Million	134,931 New	134,931 $5.15 Million

133

27.2M

108K

172K

Ticker CMPS
Exchange NASDAQ
Sector Healthcare
Industry Medical Care Facilities
Shares Outstandng 42,522,400
Market Cap $363M
Description
COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.